Aberman Zami 4
4 · PLURISTEM THERAPEUTICS INC · Filed Apr 8, 2019
Insider Transaction Report
Form 4
Aberman Zami
DirectorCEO & Co. Chairman
Transactions
- Purchase
Common Stock
2019-04-08$0.70/sh+71,429$50,000→ 4,939,727 total - Purchase
Common Stock Warrant
2019-04-08+71,429→ 71,429 totalExercise: $0.70From: 2019-04-08Exp: 2024-04-08→ Common Stock (71,429 underlying)
Holdings
- 111,400(indirect: By Rose Hitech Ltd.)
Common Stock
Footnotes (2)
- [F1]The common stock and common stock warrant were acquired in the issuer's public underwritten offering of units, in which each unit consisted of one share of common stock and an accompanying common stock warrant to purchase one share of common stock, at a price of $0.70 per unit. The price paid per unit is reflected in Table I.
- [F2]The common stock warrants were exercisable immediately upon their issuance.